Clinical Trials Browser

Phase 2 × saracatinib × Dermatologic × Clear all

NCT00669019 2014-05-21

Saracatinib in Treating Patients With Stage III or Stage IV Melanoma That Cannot Be Removed By Surgery

Phase 2 Completed

23 enrolled 6 charts

Melanoma